NDAINJECTIONINJECTABLE1 Generic Approved
Approved
Aug 1973
Lifecycle
LOE Approaching
Competitive Pressure
45/100
Data completeness
2/8 — Basic
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
REGONOL (pyridostigmine bromide) is an injectable anticholinesterase agent that reverses neuromuscular blockade by inhibiting acetylcholine destruction at the myoneural junction. It is used perioperatively to antagonize the effects of nondepolarizing muscle relaxants following anesthesia. Pyridostigmine offers a longer duration of action and lower incidence of muscarinic side effects compared to neostigmine.
$0.042BPart D
LOE ApproachingMature asset with limited growth potential as loss of exclusivity approaches; expect focus on operational efficiency and market defense rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on REGONOL offers 520 linked career opportunities, primarily in commercial, legal, and quality assurance functions at Novartis. As a mature asset approaching LOE, roles emphasize regulatory compliance, operational efficiency, and defensive market strategies rather than growth-oriented brand building.
DirectorAllergy Territory Account Specialist
Worked on REGONOL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.